Kimer Med, The New Zealand Biotech Leading The Charge Against Viral Disease
Ground-breaking New Zealand biotech start-up, Kimer Med, has kicked off a capital raise to complete pre-clinical studies on its broad-spectrum antivirals, ahead of phase 1 clinical trials. The company has spent the past three years working on the ...